Skip to main content
Log in

Use of a New Hybrid Heparin-Bonded Nitinol Ring Stent in the Popliteal Artery: Procedural and Mid-term Clinical and Anatomical Outcomes

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To report the immediate and mid-term clinical and anatomical outcomes of a novel, hybrid, heparin-bonded, nitinol ring stent (TIGRIS; Gore Medical) when used for the treatment of lesions located in the popliteal artery.

Materials and Methods

This was a prospective single-centre registry. Patients eligible for inclusion were individuals suffering from symptomatic popliteal arterial occlusive disease (Rutherford–Becker stage 3–6; P1–P3 segments) and treated with placement of the TIGRIS stent(s). Patients were prospectively scheduled for clinical review and duplex ultrasound follow-up after 6 and 12 months. Outcome measures included immediate technical success, primary vessel patency, in-stent binary restenosis (evaluable by Duplex at 50 % threshold; PSVR > 2.0), freedom from target lesion revascularization (TLR) and amputation-free survival (AFS) estimated by Kaplan–Meier (K–M) survival analysis. Cox proportional-hazards regression analysis was also performed to adjust for confounders and search for independent predictors of outcomes.

Results

From August 2012 to March 2014, a total of 54 popliteal TIGRIS stents were implanted in 50 limbs of 48 patients (27 men and 21 women; mean age 76.0 ± 1.7 years). Median Rutherford–Becker stage was five at baseline and 37/50 (74.0 %) were chronic total occlusions. Technical success was achieved in all cases (100 %). Stented lesion length was 114.2 ± 36.9 mm (range 6–20 cm). Median follow-up was 11.8 ± 0.8 months. After 12 months, primary patency of the TIGRIS stent was 69.5 ± 10.2 % with an 86.1 ± 5.9 % freedom from TLR and 87 ± 5.0 % AFS (K–M estimates).

Conclusion

The TIGRIS hybrid heparin-bonded nitinol ring stent is a safe and effective endovascular option for complex occlusive disease of the popliteal artery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Diamantopoulos A, Katsanos K. Treating femoropopliteal disease: established and emerging technologies. Semin Intervent Radiol. 2014;31(4):345–52.

    Article  PubMed  Google Scholar 

  2. Katsanos K, Spiliopoulos S, Karunanithy N, Krokidis M, Sabharwal T, Taylor P. Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery. J Vasc Surg. 2014;59(4):1123–33 e1128.

    Article  PubMed  Google Scholar 

  3. Katsanos K, Tepe G, Tsetis D, Fanelli F. Standards of practice for superficial femoral and popliteal artery angioplasty and stenting. Cardiovasc Intervent Radiol. 2014;37(3):592–603.

    Article  PubMed  Google Scholar 

  4. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, National Heart, Lung, and Blood Institute, Society for Vascular Nursing, Trans Atlantic Inter-Society Consensus, and Vascular Disease Foundation. Circulation. 2006;113(11):e463–654.

    Article  PubMed  Google Scholar 

  5. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–67.

    Article  PubMed  Google Scholar 

  6. Bosiers M, Torsello G, Gissler HM, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther. 2009;16(3):261–9.

    Article  PubMed  Google Scholar 

  7. Krankenberg H, Schluter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116(3):285–92.

    Article  CAS  PubMed  Google Scholar 

  8. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3(3):267–76.

    Article  PubMed  Google Scholar 

  9. Scheinert D, Werner M, Scheinert S, et al. Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry. JACC Cardiovasc Interv. 2013;6(1):65–71.

    Article  PubMed  Google Scholar 

  10. Hoffmann U, Vetter J, Rainoni L, Leu AJ, Bollinger A. Popliteal artery compression and force of active plantar flexion in young healthy volunteers. J Vasc Surg. 1997;26(2):281–7.

    Article  CAS  PubMed  Google Scholar 

  11. Kroger K, Santosa F, Goyen M. Biomechanical incompatibility of popliteal stent placement. J Endovasc Ther. 2004;11(6):686–94.

    Article  PubMed  Google Scholar 

  12. Piorkowski M, Freitas B, Schmidt A, et al. The use of the GORE(R) TIGRIS(R) vascular stent with dual component design in the superficial femoral and popliteal arteries at 6 months. J Cardiovasc Surg (Torino). 2013;54(4):447–53.

    CAS  Google Scholar 

  13. Mechanical properties of the GORE TIGRIS vascular stent. Available at: http://www.goremedical.com/resources/dam/assets/AR0092-EU2.pdf. Accessed April 2015.

  14. Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol. 1992;18(5):433–40.

    Article  CAS  PubMed  Google Scholar 

  15. Lammer J, Bosiers M, Zeller T, et al. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg. 2011;54(2):394–401.

    Article  PubMed  Google Scholar 

  16. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354(18):1879–88.

    Article  CAS  PubMed  Google Scholar 

  17. Dake MD, Ansel GM, Jaff MR, et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol. 2013;61(24):2417–27.

    Article  CAS  PubMed  Google Scholar 

  18. Diamantopoulos A, Katsanos K. Treating femoropopliteal disease: established and emerging technologies. Semin Intervent Radiol. 2014;31(4):345–52.

    Article  PubMed  Google Scholar 

  19. Scheinert D, Grummt L, Piorkowski M, et al. A novel self-expanding interwoven nitinol stent for complex femoropopliteal lesions: 24-month results of the SUPERA SFA registry. J Endovasc Ther. 2011;18(6):745–52.

    Article  PubMed  Google Scholar 

  20. Chang IS, Chee HK, Park SW, et al. The primary patency and fracture rates of self-expandable nitinol stents placed in the popliteal arteries, especially in the P2 and P3 segments, in Korean patients. Korean J Radiol. 2011;12(2):203–9.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Piorkowski M, Freitas B, Steiner S, et al. Twelve-month experience with the GORE(R) TIGRIS(R) Vascular Stent in the superficial femoral and popliteal arteries. J Cardiovasc Surg (Torino). 2014;56:89.

    Google Scholar 

  22. Goltz JP, Ritter CO, Kellersmann R, Klein D, Hahn D, Kickuth R. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force. J Endovasc Ther. 2012;19(3):450–6.

    Article  PubMed  Google Scholar 

  23. Semaan E, Hamburg N, Nasr W, et al. Endovascular management of the popliteal artery: comparison of atherectomy and angioplasty. Vasc Endovascular Surg. 2010;44(1):25–31.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Strecker EP, Boos IB, Gottmann D, Vetter S, Haase W. Popliteal artery stenting using flexible tantalum stents. Cardiovasc Intervent Radiol. 2001;24(3):168–75.

    Article  CAS  PubMed  Google Scholar 

  25. Werner M, Paetzold A, Banning-Eichenseer U, et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention. 2014;10(7):861–8.

    Article  PubMed  Google Scholar 

  26. Kawarada O, Higashimori A, Noguchi M, et al. Duplex criteria for in-stent restenosis in the superficial femoral artery. Catheter Cardiovasc Interv. 2013;81(4):E199–205.

    Article  PubMed  Google Scholar 

  27. Rastan A, Krankenberg H, Baumgartner I, et al. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial. Circulation. 2013;127(25):2535–41.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

None.

Conflicts of interest

Dr. A. Parthipun, Dr. A. Diamantopoulos, Dr. P. Kitrou, Dr. S. Padayachee, Dr. Karunanithy, Dr. I. Ahmed and Mr. H. Zayed have no conflicts of interest to report. Corresponding author Dr. K. Katsanos has received lectures’ honoraria and travel sponsorship in relationship to this work as well as research support by Gore Medical for a project unrelated to this work.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Konstantinos Katsanos.

Additional information

Aneeta Parthipun and Athanasios Diamantopoulos have equal contribution in this work and both qualify for first authorship position.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Parthipun, A., Diamantopoulos, A., Kitrou, P. et al. Use of a New Hybrid Heparin-Bonded Nitinol Ring Stent in the Popliteal Artery: Procedural and Mid-term Clinical and Anatomical Outcomes. Cardiovasc Intervent Radiol 38, 846–854 (2015). https://doi.org/10.1007/s00270-015-1113-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-015-1113-4

Keywords

Navigation